down arrow

Suven Pharma

  • Market Cap: Large Cap
  • Industry: Pharmaceuticals & Drugs
  • ISIN: INE03QK01018
  • NSEID: SUVENPHAR
  • BSEID: 543064
INR
1,120.85
68.65 (6.52%)
BSENSE

Apr 11, 12:53 PM

BSE+NSE Vol: 3.22 lacs

  • Price Points
  • Score
  • Mojo Parameters
  • Total Return
  • News and Corporate Actions
  • Key factors
  • Shareholding
  • Financials
  • CompanyCV
stock-recommendationNine Monthly Results
Results Snapshot
Figures in Rs cr
Consolidate Nine Monthly Results
Dec'24
Dec'23
Dec'22
Dec'21
Dec'20
Dec'19
Net Sales
795.56
798.42
970.97
956.38
750.55
649.03
Other Operating Income
0.00
0.00
0.00
0.00
0.00
0.00
Total Operating income
795.56
798.42
970.97
956.38
750.55
649.03
Raw Material Cost
152.42
194.45
334.53
329.18
222.94
176.00
Purchase of Finished goods
0.00
0.00
0.00
0.00
0.00
0.00
(Increase) / Decrease In Stocks
18.87
36.86
-41.82
-40.41
-12.36
0.22
Employee Cost
160.78
92.11
84.91
69.36
59.72
47.73
Power Cost
0.00
0.00
0.00
0.00
0.00
0.00
Manufacturing Expenses
27.08
61.55
135.81
128.84
89.12
78.64
Selling and Distribution Expenses
0.00
6.56
6.58
8.21
9.55
10.72
Other Expenses
134.77
75.89
53.50
38.79
33.69
28.22
Total Expenditure (Excl Depreciation)
493.92
467.42
573.51
533.97
402.66
341.53
Operating Profit (PBDIT) excl Other Income
301.64
331.00
397.46
422.41
347.89
307.50
Other Income
47.99
44.85
34.96
75.51
10.94
12.78
Operating Profit (PBDIT)
349.63
375.85
432.42
497.92
358.83
320.28
Interest
6.60
3.81
3.13
4.04
8.38
15.85
Exceptional Items
0.00
0.00
0.00
0.00
0.00
0.00
Gross Profit (PBDT)
343.03
372.04
429.29
493.88
350.45
304.43
Depreciation
50.71
37.22
35.78
28.68
23.32
16.54
Profit Before Tax
292.32
334.82
393.51
465.20
327.13
287.88
Tax
66.28
87.92
106.20
144.17
82.97
72.31
Provisions and contingencies
0.00
0.00
0.00
0.00
0.00
0.00
Profit After Tax
226.04
246.90
287.32
321.03
244.16
215.57
Extraordinary Items
0.00
0.00
0.00
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
0.00
0.00
0.00
Net Profit
226.04
246.90
287.32
321.03
244.16
215.57
Share in Profit of Associates
0.00
0.00
0.00
41.11
35.07
27.25
Minority Interest
0.64
0.00
0.00
0.00
0.00
0.00
Other related items
0.00
0.00
0.00
0.00
0.00
0.00
Consolidated Net Profit
225.86
246.90
287.32
362.14
279.23
242.82
Equity Capital
25.46
25.46
25.46
25.46
25.46
12.73
Face Value
1.0
1.0
1.0
1.0
1.0
1.0
Reserves
0.00
0.00
0.00
0.00
0.00
0.00
Diluted Earnings per share
3.23
1.84
4.23
6.29
4.46
4.55
Operating Profit Margin (Excl OI)
37.92%
41.46%
40.93%
44.17%
46.35%
47.38%
Gross Profit Margin
43.12%
46.6%
44.21%
51.64%
46.69%
46.91%
PAT Margin
28.41%
30.92%
29.59%
33.57%
32.53%
33.21%
Public Share Holdings (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Pledged Promotor Holding (%)
0.0%
0.0%
0.0%
0.0%
0.0%
0.0%
Nine Monthly Analysis Highlights
stock-summary

Net Sales

YoY Growth in nine months ended Dec 2024 is -0.36% vs -17.77% in Dec 2023

stock-summary

Consolidate Net Profit

YoY Growth in nine months ended Dec 2024 is -8.52% vs -14.07% in Dec 2023

stock-summary

Operating Profit (PBDIT) excl Other Income

YoY Growth in nine months ended Dec 2024 is -8.87% vs -16.72% in Dec 2023

stock-summary

Interest

YoY Growth in nine months ended Dec 2024 is 73.23% vs 21.73% in Dec 2023

stock-summary

Operating Profit Margin (Excl OI)

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023

Compare Nine Monthly Results Of Suven Pharma With
Markets Mojo
Figures in Rs cr
Consolidate Nine Monthly Results
Markets Mojo
Markets Mojo
Change(INR)
Change(%)
Net Sales
795.56
9,199.93
-8,404.37
-91.35%
Other Operating Income
0.00
0.00
0.00
Total Operating income
795.56
9,199.93
-8,404.37
-91.35%
Raw Material Cost
152.42
1,471.08
-1,318.66
-89.64%
Purchase of Finished goods
0.00
1,244.57
-1,244.57
-100.00%
(Increase) / Decrease In Stocks
18.87
-93.01
111.88
120.29%
Employee Cost
160.78
1,989.92
-1,829.14
-91.92%
Power Cost
0.00
0.00
0.00
Manufacturing Expenses
27.08
0.00
27.08
Selling and Distribution Expenses
0.00
0.00
0.00
Other Expenses
134.77
2,225.77
-2,091.00
-93.95%
Total Expenditure (Excl Depreciation)
493.92
6,838.33
-6,344.41
-92.78%
Operating Profit (PBDIT) excl Other Income
301.64
2,361.60
-2,059.96
-87.23%
Other Income
47.99
287.35
-239.36
-83.30%
Operating Profit (PBDIT)
349.63
2,648.95
-2,299.32
-86.80%
Interest
6.60
238.94
-232.34
-97.24%
Exceptional Items
0.00
0.00
0.00
Gross Profit (PBDT)
343.03
2,410.01
-2,066.98
-85.77%
Depreciation
50.71
405.66
-354.95
-87.50%
Profit Before Tax
292.32
2,007.79
-1,715.47
-85.44%
Tax
66.28
427.80
-361.52
-84.51%
Provisions and contingencies
0.00
0.00
0.00
Profit After Tax
226.04
1,576.55
-1,350.51
-85.66%
Extraordinary Items
0.00
0.00
0.00
Prior Period Expenses
0.00
0.00
0.00
Other Adjustments
0.00
0.00
0.00
Net Profit
226.04
1,576.55
-1,350.51
-85.66%
Share in Profit of Associates
0.00
9.92
-9.92
-100.00%
Minority Interest
0.64
-7.70
8.34
108.31%
Other related items
0.00
0.00
0.00
Consolidated Net Profit
225.86
1,570.19
-1,344.33
-85.62%
Equity Capital
25.46
40.06
-14.60
-36.45%
Face Value
1.00
1.00
0.00
Reserves
0.00
0.00
0.00
Gross Profit Margin
43.12%
26.20%
0.00
16.92%
PAT Margin
28.41%
17.14%
0.00
11.27%
Public Share Holdings (%)
0.00%
0.00%
0.00
0.00%
Pledged Promotor Holding (%)
0.00%
0.00%
0.00
0.00%
Nine Monthly - Net Sales
Net Sales 795.56 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -0.36% vs -17.77% in Dec 2023

Nine Monthly - Consolidate Net Profit
Consolidate Net Profit 225.86 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -8.52% vs -14.07% in Dec 2023

Nine Monthly - Operating Profit (PBDIT)
Operating Profit (PBDIT) 301.64 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is -8.87% vs -16.72% in Dec 2023

Nine Monthly - Interest
Interest 6.60 Cr
in Dec 2024

Figures in Rs Cr
stock-summary

YoY Growth in nine months ended Dec 2024 is 73.23% vs 21.73% in Dec 2023

Nine Monthly - Operating Profit Margin (Excl OI)
Operating Profit Margin (Excl OI) 37.92%
in Dec 2024

Figures in Rs %
stock-summary

YoY Growth in nine months ended Dec 2024 has fallen from Dec 2023